1 year return (CAGR)
1222.81%
Akari Therapeutics PLC Exchange (NASDAQ, USD)
AKTX
10.06
+0.40 (+4.14%)
HealthcareBiotechnology
Loading...
3 year return (CAGR)
39.64%
5 year return (CAGR)
-22.85%
10 year return (CAGR)
-26.29%
Objective Corporation Stock Analysis – State Within State
Read MoreMarketcap
19.59M
Price/Sales
-
Ent value
31.92M
Price/Book
1.05
Div yield
0.00%
Growth years
-
Div growth
-
FCF payout
0.00%
Trailing P/E
-
PEG
-
Forward P/E
-
EPS growth
116.46%
Stock information
What is a stock exchange? Operation, actors, examples
Read MoreStock chart
Loading...
Stock price data
| Open | 9.90 |
| Daily high | 10.10 |
| Daily low | 9.56 |
| Daily Volume | 47K |
| All-time high | 5000.00 |
| 1y analyst estimate | 28.50 |
| Beta | 1.43 |
| EPS (TTM) | -17.28 |
| Dividend per share | 0.00 |
| Ex-div date | - |
| Next earnings date | - |
Downside potential
Loading...
Downside potential data
| AKTX | S&P500 | |
| Current price drop from All-time high | -99.80% | -1.38% |
| Highest price drop | -100.00% | -56.47% |
| Date of highest drop | 30 Mar 2026 | 9 Mar 2009 |
| Avg drop from high | -96.60% | -10.68% |
| Avg time to new high | 1568 days | 12 days |
| Max time to new high | 3134 days | 1805 days |
News
